A Phase 2 Study of HB0017 in Psoriasis Patients

Clinical trial NCT06592274 · RECRUITING

Trial details

NCT number: NCT06592274
Sponsor: Huabo Biopharm Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis (PsO)

Start date: 2024-09-30
Primary completion: 2025-04-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.